Jade Biosciences, Inc.JBIO
Price (close)
$14.73
Market cap
$936.2M
P/E
—
Revenue (TTM)
—
Net income
-$153.2M
Dividend yield
—
1-year total return
82.8%
Net margin
—
Revenue growth
—
Debt / equity
—
What Jade Biosciences, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | -$9.6M | -$23.0M | -$51.5M | -$75.5M | -$69.6M | -$127.4M |
| Free cash flow | — | -$27.6M | -$39.3M | -$56.9M | — | -$94.9M |
More on JBIO.
- Jade Biosciences, Inc. summary
- Jade Biosciences, Inc. financial statements
- Jade Biosciences, Inc. key metrics
- Jade Biosciences, Inc. health scores and style box
- Jade Biosciences, Inc. earnings
- Jade Biosciences, Inc. dividends
- Jade Biosciences, Inc. valuation
- Jade Biosciences, Inc. ownership and insiders
- Jade Biosciences, Inc. peers
Figures from Jade Biosciences, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.